# Interferon Beta in Treating Patients With Metastatic Cutaneous Melanoma or Ocular Melanoma

> **NCT00085306** · PHASE2 · COMPLETED · sponsor: **Case Comprehensive Cancer Center** · enrollment: 21 (actual)

## Conditions studied

- Stage IV Melanoma
- Recurrent Melanoma

## Interventions

- **BIOLOGICAL:** recombinant interferon beta

## Key facts

- **NCT ID:** NCT00085306
- **Lead sponsor:** Case Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2007-10
- **Final completion:** 2007-10
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2015-10-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00085306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00085306, "Interferon Beta in Treating Patients With Metastatic Cutaneous Melanoma or Ocular Melanoma". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00085306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*